144 related articles for article (PubMed ID: 9923398)
1. Positive inotropy due to lowering cyclic GMP is also mediated by increases in cyclic AMP in control and hypertrophic hearts.
Naim KL; Rabindranauth P; Weiss HR; Tse J; Leone RJ; Scholz PM
Can J Physiol Pharmacol; 1998 Jun; 76(6):605-12. PubMed ID: 9923398
[TBL] [Abstract][Full Text] [Related]
2. Positive functional effects of milrinone and methylene blue are not additive in control and hypertrophic canine hearts.
Leone RJ; Weiss HR; Scholz PM
J Surg Res; 1998 Jun; 77(1):23-8. PubMed ID: 9698527
[TBL] [Abstract][Full Text] [Related]
3. Effect of cyclic GMP reduction on regional myocardial mechanics and metabolism in experimental left ventricular hypertrophy.
Guo X; Kedem J; Weiss HR; Tse J; Roitstein A; Scholz PM
J Cardiovasc Pharmacol; 1996 Mar; 27(3):392-400. PubMed ID: 8907801
[TBL] [Abstract][Full Text] [Related]
4. The negative functional and metabolic effects of muscarinic stimulation are enhanced by beta-adrenergic activation in control and hypertrophic dog hearts in vivo.
Scholz PM; Rabindranauth P; Naim KL; Weiss HR; Tse J
Basic Res Cardiol; 1997 Dec; 92(6):391-401. PubMed ID: 9464863
[TBL] [Abstract][Full Text] [Related]
5. Increased guanylate cyclase activity is associated with an increase in cyclic guanosine 3',5'-monophosphate in left ventricular hypertrophy.
Sadoff JD; Scholz PM; Tse J; Weiss HR
J Clin Invest; 1996 Aug; 98(3):838-45. PubMed ID: 8698876
[TBL] [Abstract][Full Text] [Related]
6. Cyclic GMP attenuates cyclic AMP-stimulated inotropy and oxygen consumption in control and hypertrophic hearts.
Leone RJ; Straznicka M; Scholz PM; Weiss HR
Basic Res Cardiol; 2000 Feb; 95(1):28-38. PubMed ID: 10752543
[TBL] [Abstract][Full Text] [Related]
7. Pacing-induced cardiac failure of hypertrophic hearts: effects of cyclic GMP reduction.
Huang MW; Weiss HR; Tse J; Leone RJ; Scholz PM
J Surg Res; 1999 Sep; 86(1):89-96. PubMed ID: 10452873
[TBL] [Abstract][Full Text] [Related]
8. Cyclic GMP and cyclic AMP induced changes in control and hypertrophic cardiac myocyte function interact through cyclic GMP affected cyclic-AMP phosphodiesterases.
Weiss HR; Gong GX; Straznicka M; Yan L; Tse J; Scholz PM
Can J Physiol Pharmacol; 1999 Jun; 77(6):422-31. PubMed ID: 10537228
[TBL] [Abstract][Full Text] [Related]
9. Relationship between cyclic-AMP content, regional myocardial function and O2 consumption in experimental left ventricular hypertrophy: effect of negative inotropes.
Scholz PM; Chiu WC; Kedem J; Weiss HR
Life Sci; 1993; 53(24):1847-58. PubMed ID: 8246683
[TBL] [Abstract][Full Text] [Related]
10. The effect of intracoronary nitroprusside on cyclic GMP and regional mechanics is altered in a canine model of left ventricular hypertrophy.
Roitstein A; Kedem J; Cheinberg B; Weiss HR; Tse J; Scholz PM
J Surg Res; 1994 Nov; 57(5):584-90. PubMed ID: 7967596
[TBL] [Abstract][Full Text] [Related]
11. Heart failure reduces both the effects and interaction between cyclic GMP and cyclic AMP.
Moalem J; Weiss HR; Davidov T; Rodriguez R; Molino B; Lazar MJ; Scholz PM
J Surg Res; 2006 Aug; 134(2):300-6. PubMed ID: 16545395
[TBL] [Abstract][Full Text] [Related]
12. Altered effects of acetylcholine on cyclic AMP and GMP induced changes in O2 consumption of hypertrophic dog cardiac myocytes.
Gong GX; Straznicka M; Weiss HR; Tse J; Scholz PM
J Auton Pharmacol; 1999 Feb; 19(1):19-28. PubMed ID: 10385266
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide reduces myocardial contractility in isoproterenol-stimulated rat hearts by a mechanism independent of cyclic GMP or cyclic AMP.
Weiss HR; Sadoff JD; Scholz PM; Klabunde RE
Pharmacology; 1997 Oct; 55(4):202-10. PubMed ID: 9396080
[TBL] [Abstract][Full Text] [Related]
14. Milrinone, a cyclic AMP-phosphodiesterase inhibitor, has differential effects on regional myocardial work and oxygen consumption in experimental left ventricular hypertrophy.
Chiu WC; Kedem J; Weiss HR; Tse J; Cheinberg BV; Scholz PM
Cardiovasc Res; 1994 Sep; 28(9):1360-5. PubMed ID: 7954646
[TBL] [Abstract][Full Text] [Related]
15. Effects of beta-adrenoceptor stimulation on pacing-induced failure of dog hypertrophic hearts.
Huang MW; Leone RJ; Weiss HR; Tse J; Scholz PM
Clin Exp Pharmacol Physiol; 2000 Mar; 27(3):202-7. PubMed ID: 10744348
[TBL] [Abstract][Full Text] [Related]
16. Increased O2 consumption and positive inotropy caused by cyclic GMP reduction are not altered after L-type calcium channel blockade.
Leone RJ; Naim KL; Scholz PM; Weiss HR
Pharmacology; 1998 Jan; 56(1):37-45. PubMed ID: 9467186
[TBL] [Abstract][Full Text] [Related]
17. Reduced myocardial cyclic GMP increases myocardial O2 consumption in control but not renal hypertension-induced cardiac hypertrophy.
Sadoff JD; Scholz PM; Tse J; Weiss HR
Cardiovasc Res; 1997 Dec; 36(3):453-9. PubMed ID: 9534866
[TBL] [Abstract][Full Text] [Related]
18. Local inotropic stimulation by methylene blue does not improve mechanical dysfunction due to myocardial stunning.
Naim KL; Weiss HR; Guo X; Sadoff J; Scholz P; Kedem J
Res Exp Med (Berl); 1997; 197(1):23-35. PubMed ID: 9226760
[TBL] [Abstract][Full Text] [Related]
19. Effect of dopamine on regional myocardial function and oxygen consumption in experimental left ventricular hypertrophy.
Wright C; Weiss HR; Kedem J; Scholz PM
Basic Res Cardiol; 1991; 86(5):449-60. PubMed ID: 1837451
[TBL] [Abstract][Full Text] [Related]
20. Down regulation of myocardial beta1-adrenoceptor signal transduction system in pacing-induced failure in dogs with aortic stenosis-induced left ventricular hypertrophy.
Tse J; Huang MW; Leone RJ; Weiss HR; He YQ; Scholz PM
Mol Cell Biochem; 2000 Feb; 205(1-2):67-73. PubMed ID: 10821423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
